Non Valvular Atrial Fibrillation clinical trials

Explore recruiting non valvular atrial fibrillation clinical trials.

Recruiting non valvular atrial fibrillation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Valvular Atrial Fibrillation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non valvular atrial fibrillation: a randomized controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study comparing the new drug PG413 produced by Celon Pharma SA with the drug Eliquis available on the market in healthy volunteers.

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing apixaban 5 mg hard capsules (PG412 [Celon Pharma]) vs apixaban 5 mg film-coated tablets (Eliquis [Bristol-Myers Squibb]) under fasting conditions in healthy volunteers

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Non Valvular Atrial Fibrillation trials by city

Non Valvular Atrial Fibrillation in Toronto Non Valvular Atrial Fibrillation in Vancouver Non Valvular Atrial Fibrillation in Montreal Non Valvular Atrial Fibrillation in Calgary Non Valvular Atrial Fibrillation in Edmonton Non Valvular Atrial Fibrillation in Ottawa Non Valvular Atrial Fibrillation in Winnipeg Non Valvular Atrial Fibrillation in Quebec City Non Valvular Atrial Fibrillation in Hamilton Non Valvular Atrial Fibrillation in Kitchener Non Valvular Atrial Fibrillation in London Non Valvular Atrial Fibrillation in Halifax Non Valvular Atrial Fibrillation in New York Non Valvular Atrial Fibrillation in Los Angeles Non Valvular Atrial Fibrillation in Chicago Non Valvular Atrial Fibrillation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease